The first human study to be conducted comparing the effects of modern wheat versus Khorasan (kamut) wheat on people suffering from a chronic health problem, irritable bowell syndrome, Effect of Triticum turgidum subsp. turanicum wheat on irritable bowel syndrome: a double-blinded randomized dietary intervention trial, showed that a diet of Khorasan ancient grain increased anti-inflammatory and antioxidant activity in the body in comparison to a diet of modern wheat.

The study was published online in the British Journal of Nutrition, February 13, 2014. The aim of the present study was to examine the effect of a replacement diet with organic, semi-whole-grain products derived from Khorasan (ancient) wheat on irritable bowel syndrome (IBS) symptoms and inflammatory/biochemical parameters. A double-blinded randomised cross-over trial was performed with twenty participants (thirteen females and seven males, aged 18–59 years) classified as having moderate IBS.

Participants received products (bread, pasta, biscuits and crackers) made either from ancient or modern wheat for 6 weeks in a random order. Symptoms due to IBS were evaluated using two questionnaires, which were compiled both at baseline and on a weekly basis during the intervention period. Study author, F. Sofi et al, said: “In conclusion, significant improvements in both IBS symptoms and the inflammatory profile were reported after the ingestion of ancient wheat products.” Bob Quinn, founder of Kamut International and organic farmer said: “We’re pleased to see the first human study of chronically ill people conclude with results that are consistent with the previously conducted studies with healthy people comparing KAMUT® Khorasan wheat to modern wheat.” “It is a significant step in helping us understand how different wheat functions in our bodies and how a shift in our diet can make such a positive impact on our health.”